Vertex, ahead of FDA decision, calms fears surrounding kidney drug
BioPharma DiveJacob BellNovember 3, 2026
On a conference call, executives expressed conviction in the coming launch of an IgA nephropathy medicine viewed by Wall Street investors as important to Vertex s future.